Cargando…
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
BACKGROUND: Prostate cancer is one of the most prevalent cancers in males in the United States and amongst the leading causes of cancer related deaths. A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374594/ https://www.ncbi.nlm.nih.gov/pubmed/28361666 http://dx.doi.org/10.1186/s12859-017-1522-2 |